![Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study]()
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre studyRichtig, Georg; Hoeller, Christoph; Wolf, Martin; Wolf, Ingrid; Rainer, Barbara M.; Schulter, Günter; Richtig, Markus; Grübler, Martin R.; Gappmayer, Anna; Haidn, Thomas; Kofler, Julian; Huegel, Rainer; Lange-Asschenfeldt, Bernhard; Pichler, Martin; Pilz, Stefan; Heinemann, Akos; Richtig, Erika; Haass, Nikolas K. · PLOS ONE · 2018